ArticleBMC public health2025
Global, regional, and national burden of maternal hypertensive disorder: 1990-2021 analysis and future projections.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Global and Regional Impact of Pelvic Inflammatory Disease in Females Across All Age Groups (1990-2021) with Projections to 2046: Findings from the 2021 Global Burden of Disease Study.International journal of women's health · 2026Article
- Magnesium sulfate pharmacology for maternal and critical-care indications: mechanisms, pharmacokinetics, and the therapeutic window.Frontiers in pharmacology · 2026Review
- Nonlinear association between wet-bulb globe temperature and maternal hypertensive disorders burden: a global analysis from 1990 to 2021.Frontiers in public health · 2025Article
- Global burden of tuberculosis attributable to diet low in whole grains from 1990 to 2021, with projection to 2045.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMaternal hypertensive disorder seriously threatens maternal and neonatal health, contributing to high morbidity and mortality globally. Existing studies on its burden have limitations, like limited data periods or a lack of focus. There's a need for a comprehensive analysis.
methodsThis study utilized GBD 2021 data to systematically evaluate the global, regional, and national burden of Maternal hypertensive disorder from 1990 to 2021. It assessed deaths and Disability-Adjusted Life Years, explored temporal trends with linear regression, analyzed regional patterns via cluster analysis, identified burden change drivers using decomposition analysis, estimated achievable outcomes through frontier analysis, and predicted future trends with the Bayesian model for age-period-cohort for better public health planning.
resultsFrom 1990 to 2021, the global age-standardized incidence, prevalence, mortality, and Disability-Adjusted Life Years rates of Maternal hypertensive disorder decreased to 227.96,44.42,0.48, and 31.29 per 100,000, respectively. Based on Bayesian model for the age-period-cohort projections, they will continue to decline to 2046. However, there were marked disparities. Low-Socio-Development Index regions had a heavier burden, and some regions like parts of Latin America & Caribbean saw an increase, while East Asia had a decrease. Aging, population growth, and epidemiological changes had different effects on the burden across regions.
conclusionsThis study suggests that targeted public health policies are essential. Low-income regions must enhance healthcare infrastructure and promote family planning, while high-income areas should focus on the aging maternal population. However, the study has limitations concerning data accuracy and model assumptions. Future research should strive to improve data quality and analytical models to better address maternal health disparities and enhance maternal health outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.